(Q50583839)

16 March 2018

title

Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients (English)

1 reference

16 March 2018

1 reference

1 reference

Dereure O

1

1 reference

16 March 2018

Raison-Peyron N

2

1 reference

16 March 2018

Larrey D

3

1 reference

16 March 2018

Blanc F

4

1 reference

16 March 2018

Guilhou JJ

5

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 December 2002

1 reference

16 March 2018

British Journal of Dermatology

published in

1 reference

16 March 2018

volume

147

1 reference

16 March 2018

issue

6

1 reference

16 March 2018

page(s)

1142-1146

1 reference

16 March 2018

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

Cutaneous reactions to recombinant cytokine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

[Pilot study of the effect of interferon-alpha on atopic eczema].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

Severe cutaneous reactions following interferon injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

Dermatologic disease during interferon-alpha therapy for chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

Clinical and immunohistochemical studies of skin eruptions: relationship to administration of interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

Interferon-alpha for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

Interferon-alpha treatment for severe atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04897.X

10.1046/J.1365-2133.2002.04897.X

21 January 2018

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018